Home / News / World News / Article /
US approves Malaria drug to treat COVID-19 patients
Updated On: 31 March, 2020 06:21 AM IST | Washington | Agencies
An inexpensive drug widely used since 1955 to treat malaria, Hydroxychloroquine is considered to have relatively harmless side effects

Medical workers wear protective masks while delivering a patient to the emergency room at Brooklyn Hospital Center on Monday. Pic/AP/PTI
Malaria medicine 'Hydroxychloroquine' is being administered to 1,100 Coronavirus patients in New York, President Trump said, exuding confidence that the drug, touted as a 'game-changer' by him, might give incredible results in the fight against the disease that has infected over 1,40,000 people in the US.
An inexpensive drug widely used since 1955 to treat malaria, Hydroxychloroquine is considered to have relatively harmless side effects. It is being tested out on the COVID-19 patients in New York on an experimental basis, hoping that this will give a positove solutions.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.

